Financial Daily from THE HINDU group of publications
Friday, Dec 02, 2005


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Corporate - Announcements


Perlecan begins phase-I trials on obesity drug

Our Bureau

Hyderabad , Dec. 1

PERLECAN Pharma Pvt Ltd, a joint venture between Dr Reddy's Laboratories, ICICI Venture Funds Management Company Ltd and Citigroup Venture Capital International Mauritius Ltd, has announced the commencement of phase-I clinical trials of its new drug candidate for treatment of obesity `DRL-11605' in Canada.

In a release here on Thursday, Perlecan said the drug candidate is being developed for the treatment of obesity with or without accompanying diabetes and lipid disorders.

Perlecan Pharma received assignment of four new chemical entities (NCEs) from Dr Reddy's Labs, including all titles and rights of the development and commercialisation.

According to the company, obesity is a growing medical problem worldwide and is a major risk factor for development of diabetes and cardiovascular disease.

The company said that DRL-11605 works by a new mechanism that activates all isoforms of PPAR receptors which control fat, lipid and glucose utilisation by the body. It represents one of the first pan-PPAR activators to be developed for treatment of obesity. In animal models of obesity, treatment with DRL-11605 has shown marked reduction in body weight and improvements in blood glucose and lipids, the release said.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

More Stories on : Announcements



Stories in this Section
ONGC may contest I-T Dept's additional claim of Rs 1,000 cr


Perlecan begins phase-I trials on obesity drug
Ranbaxy to launch 2 AIDS drugs
Colgate 30 pc second interim
USFDA nod for Lupin drug
Piramal group makes open offer for 20 pc stake in Dawn Mills
IVRCL raises $65 m through FCCBs
Terex Pegson to source components worth $2 million
Why MNCs need to create products for India, in India
HLL tea unit demerger okayed
ONGC appoints consultants for due diligence of SPIC Petro
Suryavanshi Spinning plans merger
Sical to raise funds for iron ore terminal
Nalco signs pact with NMDC
Bajaj Auto expects to grow at 17-20 pc after April
Brooke Bond initiative on education in Mangalore
Trayons promoters sign OTS pact with IDBI Bank
Siemens bets on India for Asian growth
Escorts Construction expects 40 pc turnover growth
IOC likely to be hit by pricing pressures
Maruti sales up 11% in Nov
Hero Honda Nov sales up 6.5 pc
Bajaj Auto Nov sales flat
TVS Motor sales up 5 pc


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line